Literature DB >> 19002473

[Evidence-based physiotherapeutic strategies for musculoskeletal pain].

U Lange1, U Müller-Ladner.   

Abstract

Inflammatory rheumatic disorders usually progress towards morphologic and functional deficits and thus cause substantial impairment of physical health. Amongst the therapeutic options physiotherapeutic strategies are essential and are often required to maintain the individual's quality of life. Because of the large variety of physiotherapeutical approaches, differentiated clinical examination is needed in order to implement physiotherapeutics in a treatment plan that is based on pathophysiologic and regeneration-specific aspects. The article presents a current overview of evidence-based physiotherapeutic strategies for musculoskeletal pain reduction in daily practice.

Entities:  

Mesh:

Year:  2008        PMID: 19002473     DOI: 10.1007/s00393-008-0352-z

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  27 in total

1.  A systematic review of interventions to prevent lower limb soft tissue running injuries.

Authors:  E W Yeung; S S Yeung
Journal:  Br J Sports Med       Date:  2001-12       Impact factor: 13.800

2.  Reduction in the need for operation after conservative treatment of osteoarthritis of the first carpometacarpal joint: a seven year prospective study.

Authors:  M Berggren; A Joost-Davidsson; J Lindstrand; G Nylander; B Povlsen
Journal:  Scand J Plast Reconstr Surg Hand Surg       Date:  2001-12

Review 3.  Therapies for axial disease in psoriatic arthritis. A systematic review.

Authors:  Peter Nash
Journal:  J Rheumatol       Date:  2006-05-15       Impact factor: 4.666

4.  Effects of occupational therapy home service on patients with rheumatoid arthritis.

Authors:  A Helewa; C H Goldsmith; P Lee; C Bombardier; B Hanes; H A Smythe; P Tugwell
Journal:  Lancet       Date:  1991-06-15       Impact factor: 79.321

Review 5.  Transcutaneous electrical nerve stimulation for knee osteoarthritis.

Authors:  M Osiri; V Welch; L Brosseau; B Shea; J McGowan; P Tugwell; G Wells
Journal:  Cochrane Database Syst Rev       Date:  2000

6.  Occupational therapy in ankylosing spondylitis: Short-term prospective study in patients treated with anti-TNF-alpha drugs.

Authors:  Antonio Spadaro; Tania De Luca; Maria Pia Massimiani; Fulvia Ceccarelli; Valeria Riccieri; Guido Valesini
Journal:  Joint Bone Spine       Date:  2007-09-24       Impact factor: 4.929

Review 7.  Balneotherapy for osteoarthritis.

Authors:  A P Verhagen; S M A Bierma-Zeinstra; M Boers; J R Cardoso; J Lambeck; R A de Bie; H C W de Vet
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17

Review 8.  Exercise for treating fibromyalgia syndrome.

Authors:  A J Busch; K A R Barber; T J Overend; P M J Peloso; C L Schachter
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17

Review 9.  Aquatic exercise for the treatment of knee and hip osteoarthritis.

Authors:  E M Bartels; H Lund; K B Hagen; H Dagfinrud; R Christensen; B Danneskiold-Samsøe
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17

Review 10.  Transcutaneous electrical nerve stimulation (TENS) for the treatment of rheumatoid arthritis in the hand.

Authors:  L Brosseau; M G Judd; S Marchand; V A Robinson; P Tugwell; G Wells; K Yonge
Journal:  Cochrane Database Syst Rev       Date:  2003
View more
  4 in total

1.  [Physiotherapy and ergotherapy are indispensable. Concrete prescription of remedies - without recourse].

Authors:  J-M Engel
Journal:  Z Rheumatol       Date:  2012-07       Impact factor: 1.372

2.  [Molecular physical medicine].

Authors:  U Lange
Journal:  Z Rheumatol       Date:  2012-07       Impact factor: 1.372

Review 3.  [Physiotherapy in rheumatology].

Authors:  U Lange
Journal:  Z Rheumatol       Date:  2015-10       Impact factor: 1.372

4.  [Preservation of ability to work and securing vocational participation : non-pharmaceutical support options for rheumatologists].

Authors:  Y Drambyan; K Parthier
Journal:  Z Rheumatol       Date:  2014-02       Impact factor: 1.372

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.